Drug Policy
Americans are bombarded with ads that begin with “Talk to your doctor about…” and plug in some pharmaceutical product. And many doctor-patient encounters end with a prescription of some sort. The rising cost of drugs is a major contributor to overall health costs in this country; whether or not we are getting value for money is an open question.
Moreover, a number of high-profile drugs have come under intense scrutiny in the last several years and Public Citizen has played an important role in many: Vioxx, Avandia, Viagra, Rezulin, Darvon, Meridia, Febuxostat, and Dsuvia.
Public Citizen has been assessing the quality and efficacy of drugs since its founding in 1971. When we feel that the information provided to doctors or patients is misleading, insufficient, or just plain wrong, we do not hesitate to express an opinion. Our book Worst Pills, Best Pills, our monthly print newsletter Worst Pills, Best Pills News, and our website WorstPills.org have been at the forefront of the provision of information to patients. We also use the law, petitions, and letters to monitor the FDA and coax the agency into action. Our actions have contributed to more than two dozen drugs being pulled off the market. Public Citizen has also been instrumental in getting “black box” and other warnings in the product labeling of drugs.
- Access to Medicine
- Antibiotic Resistance
- Biological Products
- Clinical Trials Design
- Conflict of Interest
- Distribution of Drug Risk Information
- Drug Approval Process
- Drug Company Practices
- Drug Labeling
- Drug Manufacturing
- Drug Patents
- Drug Pricing
- Drug Promotion
- Drug Safety
- Drug Shortages
- Ethics and Clinical Trials
- FDA Transparency
- Information for Patients
- Legislative Work
- Off-Label Use
- Opioid Drug Issues
- Over-the-Counter Drugs
- Pharmacy Compounding